Novavax Completes Enrollment of PREVENT-19, COVID-19 Vaccine Pivotal Phase 3 Trial in the United States and Mexico

GSK and CureVac to develop next generation mRNA COVID-19 vaccines

Sanofi to provide manufacturing support to Johnson & Johnson for their COVID-19 vaccine to help address global supply demands

Vetter continues its long-term investment strategy to sustain future growth

Vetter continues its successful performance at the 2021 CMO Leadership Awards

Pelican BioThermal Launches new Webinar Series

Peli BioThermal Launches new Webinar Series

Novavax Provides Phase 3 COVID-19 Vaccine Clinical Development Update

Novavax COVID-19 Vaccine Demonstrates 89.3% Efficacy in UK Phase 3 Trial

AstraZeneca's COVID-19 vaccine authorised for emergency supply in the UK

COVID-19 Vaccine AstraZeneca authorised for use in the EU

CureVac and WACKER Sign Manufacturing Contract for CureVac's COVID-19 Vaccine Candidate

Novartis signs initial agreement to provide manufacturing capacity for Pfizer-BioNTech COVID-19 vaccine

Latest News

Baxter BioPharma Solutions Announces Sterile Manufacturing Agreement for Novavax COVID-19 Vaccine

Novavax to Participate in University of Oxford Com-COV2 Study Comparing Mixed COVID-19 Vaccine Combinations

Malvern Panalytical and Concept Life Sciences announce integration

aTyr Pharma and Lonza Announce Manufacturing Agreement for aTyrs Anti-NRP2 Antibody ATYR2810

Moderna Provides Clinical and Supply Updates on COVID-19 Vaccine Program Ahead of 2nd Annual Vaccines Day

Abzena announces location of new biologics GMP manufacturing site with up to 12 X 2000L bioreactors

Lonza and Junshi Biosciences Collaborate to Accelerate the Development and Manufacturing of Biologics

Smart excipient improves powder flow for sachet-based products

SGD Pharma continues customer-led innovation with range extension for Sterinity Ready-to-Use molded glass vials

InSilicoTrials wins 3 Horizon 2020 projects to support innovation

Bora Pharmaceuticals Adds Roller Compaction Capabilities

Subscribe To Magazine

Click to View Previous Issues

Articles

Russia Expects To Register Second COVID-19 'Vaccine EpiVacCorona' By Oct 15

The Impact of COVID-19 on Rare Disease Clinical Trials

Barriers and triumphs of an underserved patient group. It is undeniable that clinical trials for rare diseases are more challenging to design and execute. Unlike...

Why pharma should embrace a multi-channel approach

Filtering with great flexibility

Providing India with Better Access to Affordable, Effective COPD Treatments

Secondary packaging: Clear strategy as success factor

COVID-19 highlights importance of data analytics in clinical trial optimisation

Hear this! Potential therapeutics for COVID-19 should be tested for auditory...

Drug Dosage Forms – Innovations That Shouldn’t Be Given A MISS

Cartridge filling: Understanding the complexities

Press Releases

Dr Reddy’s Lab gets emergency use authorisation for Sputnik V in India

Sanofi to invest in a leading-edge production site in Singapore; continues to strengthen its...

Sanofi announced a €400 million investment over five years to create a unique vaccine production...

Daiichi Sankyo begins phase 1 trial in Japan for nafamostat inhalation formulation to treat Covid-19

Airway Therapeutics Announces FDA Acceptance of IND for AT-100’s Second Indication in Severe COVID-19...

Airway Therapeutics, Inc., a biopharmaceutical company developing a new class of biologics to break the...

Catalent Biologics to Invest $30 Million to Create European Clinical Manufacturing Center of Excellence in France

Catalent Biologics Completes Madison Facility Expansion to Double Clinical and Commercial Drug Substance Capacity

Catalent, the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs,...

CEVA Logistics launches FORPATIENTS healthcare logistics sub-brand, new temperature-sensitive solution

In an expansion of its support for global healthcare and pharmaceutical customers, CEVA Logistics announced...

Most popular

Apceth Biopharma Appoints a New Supervisory Board

Apceth Biopharma GmbH, a leading company developing the next generation of cell-based therapies, announced the appointment of a new Supervisory Board. ...